Twin Health raked in $50 million in Series D financing. The startup seeks to help patients improve their metabolic health and reduce the need for medications through the “digital twin” technology it sells to employers and health plans.
For breast cancer, 20.5% of patients received a screening in the year prior to being on Medicare, compared to 30.4% in the first year of being on Medicare, according to an Epic Research report. For colorectal cancer, screening rates jumped from 6% in the year before being on Medicare to 11% in the first year of being on Medicare.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The company, which offers an AI platform that provides personalized health coaching for chronic disease patients, will use the new funds to invest in research and development and to expand its virtual integrations with health plans and employers.
ChemoCentryx has spent decades developing oral alternatives to injectable and infused biologic drugs that treat chronic autoimmune conditions. The research finally paid off with FDA approval of Tavneos, a ChemoCentryx pill for a rare autoimmune disease.
When ChristianaCare's Graham Cancer Center saw that a significant number of its patients did not have a primary care provider, they decided to take action. Now, any patient that doesn't already have a PCP is connected to one onsite at the cancer center, expanding the care each patient receives.
Providing care for chronic disease patients during a one-in-a-century pandemic is full of challenges, but health systems like Jefferson Health are finding ways — with help from technology — to make sure their patients are getting the care they need.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The MedCity INVEST Digital Health Virtual event, Sep 21-25 will spotlight healthcare startups in four categories. The application deadline is August 14 at 5pm ET.
The chronic disease management company filed its S-1 paperwork on Friday, joining Change Healthcare, Phreesia and Health Catalyst as part of the raft of companies planning to go public after a nearly three year IPO drought in digital health.